ZA907431B - Oral anticoagulant/platelet inhibitor low dose formulation - Google Patents

Oral anticoagulant/platelet inhibitor low dose formulation

Info

Publication number
ZA907431B
ZA907431B ZA907431A ZA907431A ZA907431B ZA 907431 B ZA907431 B ZA 907431B ZA 907431 A ZA907431 A ZA 907431A ZA 907431 A ZA907431 A ZA 907431A ZA 907431 B ZA907431 B ZA 907431B
Authority
ZA
South Africa
Prior art keywords
oral anticoagulant
low dose
dose formulation
platelet inhibitor
inhibitor low
Prior art date
Application number
ZA907431A
Other languages
English (en)
Inventor
William Joseph Addicks
Joseph Addicks William
Joseph A Mollica
A Mollica Joseph
Gary Howard Slatko
Howard Slatko Gary
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of ZA907431B publication Critical patent/ZA907431B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
ZA907431A 1989-09-18 1990-09-18 Oral anticoagulant/platelet inhibitor low dose formulation ZA907431B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/408,394 US5041430A (en) 1989-09-18 1989-09-18 Oral anticoagulant/platelet inhibitor low dose formulation

Publications (1)

Publication Number Publication Date
ZA907431B true ZA907431B (en) 1992-05-27

Family

ID=23616120

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA907431A ZA907431B (en) 1989-09-18 1990-09-18 Oral anticoagulant/platelet inhibitor low dose formulation

Country Status (22)

Country Link
US (1) US5041430A (fr)
EP (1) EP0493408B1 (fr)
JP (1) JPH05501109A (fr)
KR (1) KR950008307B1 (fr)
AT (1) ATE137972T1 (fr)
AU (1) AU635881B2 (fr)
CA (1) CA2065347A1 (fr)
CZ (1) CZ454090A3 (fr)
DE (1) DE69027036D1 (fr)
FI (1) FI921134A (fr)
GR (1) GR1001131B (fr)
HU (1) HUT62488A (fr)
IE (1) IE903356A1 (fr)
IL (1) IL95721A (fr)
LV (1) LV10050B (fr)
MA (1) MA21953A1 (fr)
MX (1) MX173727B (fr)
NO (1) NO920946L (fr)
NZ (1) NZ235337A (fr)
PT (1) PT95343B (fr)
WO (1) WO1991004031A1 (fr)
ZA (1) ZA907431B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5612311A (en) 1990-04-06 1997-03-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5672585A (en) * 1990-04-06 1997-09-30 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5635477A (en) * 1991-09-30 1997-06-03 The Dupont Merck Pharmaceutical Company Cyclic compounds useful as inhibitors of platelet glycoprotein IIB/IIIA
CA2100836C (fr) * 1993-07-19 1998-02-03 Bernard Charles Sherman Composition pharmaceutique
WO1996032942A1 (fr) * 1995-04-19 1996-10-24 Lipoprotein Technologies, Inc. Compositions, trousses et procedes d'administration d'antilipemiques et medicaments contre l'agregation plaquettaire
US8022095B2 (en) * 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US6121249A (en) * 1998-07-01 2000-09-19 Donald L. Weissman Treatment and prevention of cardiovascular diseases with help of aspirin, antioxidants, niacin, and certain B vitamins
IT1312088B1 (it) * 1999-04-21 2002-04-04 Altergon Sa Cerotto per uso topico contenente eparina e diclofenac.
US8173164B2 (en) * 1999-06-17 2012-05-08 Gruenenthal Gmbh Oral administration forms for administering a fixed tramadol and diclofenac combination
AU2002226986A1 (en) * 2000-12-01 2002-06-11 Rheologics, Inc. In vivo delivery methods and compositions
AU2002306461A1 (en) * 2001-03-28 2002-10-15 Rheologics, Inc. In vivo delivery methods and compositions
US7691833B2 (en) * 2002-03-01 2010-04-06 Trustees Of Dartmouth College Compositions and methods for preventing sporadic neoplasia in colon
US20050215625A9 (en) * 2003-01-08 2005-09-29 Nesselroad James M Iii Combination therapy for anticoagulation
CZ20032854A3 (cs) * 2003-10-17 2005-05-18 Pliva - Lachema A.S. Způsob přípravy dávkových jednotek pevné lékové formy obsahujících jako účinnou látku sodnou sůl warfarinu
AU2004285436C1 (en) * 2003-10-20 2009-07-16 Teva Pharmaceutical Industries Ltd. Composition and dosage form for sustained effect of levodopa
SI21637A (sl) * 2003-12-23 2005-06-30 LEK farmacevtska dru�ba d.d. Farmacevtska oblika z nadzorovanim sproščanjem
US7838031B2 (en) * 2004-05-21 2010-11-23 Lawrence Solomon Method of administering a partial dose using a segmented pharmaceutical tablet
AU2005245028B2 (en) * 2004-05-21 2010-12-09 Accu-Break Technologies, Inc. Pharmaceutical tablets having a relatively inactive segment
US20060003000A1 (en) * 2004-07-01 2006-01-05 Lawrence Solomon Adhesively bonded dosage form
US8758814B2 (en) 2004-10-08 2014-06-24 Mcneil-Ppc, Inc. Chewable enteric coated aspirin tablets
US8057820B2 (en) * 2004-10-08 2011-11-15 Mcneil-Ppc, Inc. Enteric coated aspirin granules comingled with binder
JP4613590B2 (ja) 2004-11-16 2011-01-19 セイコーエプソン株式会社 実装基板及び電子機器
WO2008082542A1 (fr) * 2006-12-19 2008-07-10 Institute For Therapeutic Research, Inc. Combinaison de vitamine k et d'un antagoniste de vitamine k, tel que l'isomère r de la warfarine, la phenprocoumone ou l'isomère r de la phenprocoumone, comme traitement anticoagulant
US20110041725A1 (en) * 2007-06-19 2011-02-24 Daniel Rittschof Anticoagulants as antifouling agents
DE102008014237A1 (de) * 2008-03-14 2009-09-17 J. Rettenmaier & Söhne Gmbh + Co. Kg Direktverpressbares Tablettierhilfsmittel
JP5529404B2 (ja) * 2008-09-05 2014-06-25 東和薬品株式会社 アスピリン腸溶錠
WO2012060847A1 (fr) * 2010-11-07 2012-05-10 Targegen, Inc. Compositions et procédés de traitement de la myélofibrose
LV14606B (lv) 2011-05-17 2013-01-20 Tetra, Sia Jauns XII faktora inhibitors
CZ304136B6 (cs) * 2012-06-27 2013-11-13 Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta Zpusob prípravy pevné lékové formy se sodnou solí warfarinu ve forme klathrátu izopropanolu
JP6304751B2 (ja) * 2014-03-24 2018-04-04 日新製薬株式会社 ワルファリン含有固形製剤及びその製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2265273A1 (en) * 1974-03-29 1975-10-24 Zootherap Laboratoires Anticoagulant-contg. rodenticidal compsn. - contg. (acetyl) salicyclic acid or salt as synergist
LU77353A1 (fr) * 1977-05-16 1979-01-19
GB2038625B (en) * 1978-12-29 1983-01-12 Parcor Therapeutic composition having an antithrombotic and antiblood-platelet-aggregating activity
EP0001503B1 (fr) * 1977-10-08 1981-01-07 Beecham Group Plc Compositions à effet antithrombotique contenant des benzisothiazolones
SU1050708A1 (ru) * 1981-04-27 1983-10-30 Горьковский государственный медицинский институт им.С.М.Кирова Способ лечени гиперкоагул ции при коронарном атеросклерозе
US4444777A (en) * 1981-07-30 1984-04-24 Bristol-Myers Company Pharmaceutical compositions of anagrelide and sulfinpyrazone
ATE50497T1 (de) * 1984-07-21 1990-03-15 Hoechst Ag Kombinationspraeparat aus pyrimido-pyrimidinen und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung.

Also Published As

Publication number Publication date
LV10050A (lv) 1994-05-10
ATE137972T1 (de) 1996-06-15
EP0493408A1 (fr) 1992-07-08
KR920703046A (ko) 1992-12-17
EP0493408B1 (fr) 1996-05-15
AU6330690A (en) 1991-04-18
PT95343A (pt) 1991-08-14
IL95721A0 (en) 1991-06-30
DE69027036D1 (de) 1996-06-20
NO920946D0 (no) 1992-03-11
WO1991004031A1 (fr) 1991-04-04
IE903356A1 (en) 1991-04-10
FI921134A0 (fi) 1992-03-17
MA21953A1 (fr) 1991-04-01
JPH05501109A (ja) 1993-03-04
NZ235337A (en) 1993-05-26
PT95343B (pt) 1998-06-30
HUT62488A (en) 1993-05-28
LV10050B (en) 1995-02-20
CA2065347A1 (fr) 1991-03-19
MX173727B (es) 1994-03-24
EP0493408A4 (en) 1992-10-07
FI921134A (fi) 1992-03-17
GR900100702A (en) 1992-01-20
US5041430A (en) 1991-08-20
AU635881B2 (en) 1993-04-01
KR950008307B1 (ko) 1995-07-27
CZ454090A3 (en) 1996-11-13
IL95721A (en) 1995-07-31
NO920946L (no) 1992-03-11
GR1001131B (el) 1993-04-28

Similar Documents

Publication Publication Date Title
IL95721A0 (en) Oral anticoagulant/platelet inhibitor low dose formulation
MX9205432A (es) Compuestos inhibidores de la biosintesis de leucotrienos y composicion farmaceutica que los contiene.
NO302366B1 (no) 4-merkaptoacetylamino-£2|benzazepinon(3)-derivater, og farmasöytisk preparat
AR042345A2 (es) Un procedimiento para la preparacion de una composicion farmaceutica para el tratamiento de aterosclerosis que contiene 8.9 - dehidroesterona o sus sales de la misma
ES511433A0 (es) "procedimiento de preparacion de productos utiles particularmente en medicamentos utilizables para el tratamiento de melanomas".
MX9202546A (es) Dimeros de rapamicina y composicion farmaceutica que los contiene.
AR027162A1 (es) Compuestos de 2-fenil-3-fenoxilo-feniltio-benzotiofeno, sales farmaceuticamente aceptables de los mismos y composiciones farmaceuticas que los contienen
NO900439D0 (no) Fremgangsmaate for behandling av uorganisk pulver.
NO912548L (no) Fremgangsmaate for behandling av avfallsprodukter.
MX9202763A (es) Nuevos derivados de 2-(1-piperazinil)-4-fenil-cicloalcanopiridina y composicion farmaceutica que los contiene.
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
IL95849A0 (en) Pharmaceutical combination containing acetylsalicylic acid and carbacyclin derivatives
NO894158D0 (no) Curcumin ved paavisning av varsling av cyanid-oppblandete naeringsmidler.
ES556806A0 (es) Un procedimiento para la preparacion de una composicion preventiva de la elastosis.
NO901422D0 (no) Fremgangsmaate for fremstilling av alfa-glucosidase-inhibitorer.
FR2707455B1 (fr) Empêchement de la reproduction des insectes xylophages, moyens pour le traitement préventif du matériau bois mis en Óoeuvre.
AR240016A1 (es) Procedimiento de preparacion de una composicion para el tratamiento de flebectasias.
NO885472D0 (no) Fremgangsmaate for belegging av gjenstander av staal.
HU9200882D0 (en) Oral anticoagulant/platelet inhibitor low dose formulation
AR240472Q (es) Un procedimiento para la preparaciond e una composicon lubricante de derivados carboxilicos.
ES1024974Y (es) Contenedor para la conservacion fisiologica temporal de piezas dentarias.
KR920700037A (ko) 치료에 유용한 혈소판 항-응집 효과를 갖는 조성물
MX9102419A (es) Compuestos novedosos, composiciones farmaceuticas que contienen a los mismos y un procedimiento parala preparacion de los mismos.
ZA892724B (en) N-alkylamino derivatives of aromatic,tricyclic compounds in the treatment of drug-resistant protozoan infections
IT8950802V0 (it) Sterilizza scarpe